Literature DB >> 17889466

The properties of bufadienolides-loaded nano-emulsion and submicro-emulsion during lyophilization.

Fang Li1, Tao Wang, Hai Bing He, Xing Tang.   

Abstract

The aim of this study was to prepare two types of emulsions, bufadienolides-loaded nano-emulsion (BU-NE) and submicro-emulsion (BU-SE) which were separately prepared by ultrasonic-high-pressure homogenization (UHPH) and high-pressure homogenization (HPH) methods, and to try to stabilize the colloid systems by lyophilization. The lyoprotective effects of cryoprotectant carbohydrates during the freeze-thawing and freeze-drying cycles on the emulsions were investigated in detail. The lyophilized products were characterized with regard to their appearance and particle size by transmission electron microscopy (TEM), scanning electron microscopy (SEM), photon correlation spectroscopy (PCS) and zeta potential. The median diameter, polydispersity index (PI) and zeta potential of BU-NE and BU-SE were 43.5 nm versus 161.4 nm, 0.100 versus 0.143 and -19.7 to -26.2 mV versus -29.4 to -35.3 mV, respectively. With the same drug content (0.28 mg mL(-1)) BU-SE exhibited a higher entrapment efficiency than BU-NE. The optimum cryoprotectant for BU-NE and BU-SE was maltose (20%) and trehalose (20%), respectively. The median diameters (95.7 and 168.5 nm) of the rehydrated BU-NE and BU-SE were slightly increased. For both of them, the bufadienolides entrapment efficiency was reduced whereas the drug content was not. The lyophilized BU-NE and BU-SE powders were stable over a period up to 3 months with no change in visual appearance, reconstitution ability, particle size distribution and drug concentration. This shows that freeze-drying could be a promising method to stabilize the emulsions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889466     DOI: 10.1016/j.ijpharm.2007.08.011

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

Review 1.  Modifications of natural peptides for nanoparticle and drug design.

Authors:  Andrew P Jallouk; Rohun U Palekar; Hua Pan; Paul H Schlesinger; Samuel A Wickline
Journal:  Adv Protein Chem Struct Biol       Date:  2015-03-12       Impact factor: 3.507

2.  The stabilization of primitive bicontinuous cubic phases with tunable swelling over a wide composition range.

Authors:  Sherry S W Leung; Cecilia Leal
Journal:  Soft Matter       Date:  2019-02-06       Impact factor: 3.679

3.  Single-vial filovirus glycoprotein vaccines: Biophysical characteristics and immunogenicity after co-lyophilization with adjuvant.

Authors:  Kendall B Preston; Teri Ann S Wong; Albert To; Taylor E Tashiro; Michael M Lieberman; Alex Granados; Karen Feliciano; John Harrison; Jake Yalley-Ogunro; Hanne Andersen Elyard; Oreola Donini; Axel T Lehrer; Theodore W Randolph
Journal:  Vaccine       Date:  2021-08-13       Impact factor: 4.169

4.  L-histidine-based pH-sensitive anticancer drug carrier micelle: reconstitution and brief evaluation of its systemic toxicity.

Authors:  Kyung T Oh; Eun Seong Lee; Dongin Kim; You Han Bae
Journal:  Int J Pharm       Date:  2008-03-13       Impact factor: 5.875

5.  Preparation of zein nanoparticles by using solution-enhanced dispersion with supercritical CO2 and elucidation with computational fluid dynamics.

Authors:  Sining Li; Yaping Zhao
Journal:  Int J Nanomedicine       Date:  2017-05-02

6.  Formation of Food Grade Microemulsion with Rice Glycosphingolipids to Enhance the Oral Absorption of Coenzyme Q10.

Authors:  Hiromasa Uchiyama; Jisoon Chae; Kazunori Kadota; Yuichi Tozuka
Journal:  Foods       Date:  2019-10-15

7.  Perfluorocarbon Nanodroplets as Potential Nanocarriers for Brain Delivery Assisted by Focused Ultrasound-Mediated Blood-Brain Barrier Disruption.

Authors:  Charlotte Bérard; Stéphane Desgranges; Noé Dumas; Anthony Novell; Benoit Larrat; Mourad Hamimed; Nicolas Taulier; Marie-Anne Estève; Florian Correard; Christiane Contino-Pépin
Journal:  Pharmaceutics       Date:  2022-07-19       Impact factor: 6.525

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.